HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Abstract
In vitro recombination techniques were used to construct a new cloning vehicle, pBR322. This plasmid, derived from pBR313, is a relaxed replicating plasmid, does not produce and is sensitive to colicin E1, and carries resistance genes to the antibiotics ampicillin (Ap) and tetracycline (Tc). The antibiotic-resistant genes on pBR322 are not transposable. The vector pBR322 was constructed in order to have a plasmid with a single PstI site, located in the ampicillin-resistant gene (Apr), in addition to four unique restriction sites, EcoRI, HindIII, BamHI and SalI. Survival of Escherichia coli strain X1776 containing pBR313 and pBR322 as a function of thymine and diaminopimelic acid (DAP) starvation and sensitivity to bile salts was found to be equivalent to the non-plasmid containing strain. Conjugal transfer of these plasmids in bi- and triparental matings were significantly reduced or undetectable relative to the plasmid ColE1.
AuthorsF Bolivar, R L Rodriguez, P J Greene, M C Betlach, H L Heyneker, H W Boyer, J H Crosa, S Falkow
JournalGene (Gene) Vol. 2 Issue 2 Pg. 95-113 ( 1977) ISSN: 0378-1119 [Print] Netherlands
PMID344137 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA, Bacterial
  • DNA, Recombinant
  • Ampicillin
  • Tetracycline
Topics
  • Ampicillin (pharmacology)
  • Conjugation, Genetic
  • DNA, Bacterial
  • DNA, Recombinant
  • Escherichia coli (genetics)
  • Plasmids
  • Recombination, Genetic
  • Tetracycline (pharmacology)
  • Transformation, Bacterial

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: